Reuters
reuters.com
did:plc:jbvnehrrdqoulco4rf5gxg5r
CSL strikes rare disease drug deal worth up to $1.6 billion with Swiss firm Alentis reut.rs/4xYNiEw https://reut.rs/4xYNiEw
2026-10-04T23:05:04.159Z
Enable JavaScript to use Bluesky.
Learn more about Bluesky at bsky.social and atproto.com.